JAK2 and viral infectious disease: Its potential efficacy in regulating immune responses, combined with its structural stability when bound to JAK2, makes it an attractive therapeutic option for viral infections such as MERS-CoV, hepatitis B, and influenza A. Future studies should focus on the in vivo evaluation of the antiviral activity of this compound to validate its clinical potential.